156 related articles for article (PubMed ID: 9652851)
1. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
Ryu S; Kim OB; Kim SH; He SQ; Kim JH
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
[TBL] [Abstract][Full Text] [Related]
2. Enhanced apoptosis and radiosensitization by combined 13-cis-retinoic acid and interferon-alpha2a; role of RAR-beta gene.
Ryu S; Stein JP; Chung CT; Lee YJ; Kim JH
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):785-90. PubMed ID: 11697325
[TBL] [Abstract][Full Text] [Related]
3. Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro.
Malone C; Schiltz PM; Nayak SK; Shea MW; Dillman RO
Clin Cancer Res; 1999 Feb; 5(2):417-23. PubMed ID: 10037192
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
5. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
[TBL] [Abstract][Full Text] [Related]
6. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of fractionated-dose irradiation by retinoic acid plus interferon.
Gerweck LE; Zaidi ST; Delaney TF
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):611-5. PubMed ID: 9806522
[TBL] [Abstract][Full Text] [Related]
8. 13-cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro.
DeLaney TF; Afridi N; Taghian AG; Sanders DA; Fuleihan NS; Faller DV; Nogueira CP
Cancer Res; 1996 May; 56(10):2277-80. PubMed ID: 8625298
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
[TBL] [Abstract][Full Text] [Related]
10. Interaction of retinoic acid and interferon in renal cancer cell lines.
Nanus DM; Geng Y; Shen R; Lai HK; Pfeffer SR; Pfeffer LM
J Interferon Cytokine Res; 2000 Sep; 20(9):787-94. PubMed ID: 11032398
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid inhibits the growth of human myeloma cells in vitro.
Palumbo A; Battaglio S; Napoli P; Bruno B; Omedè P; Boccadoro M; Pileri A
Br J Haematol; 1995 Mar; 89(3):555-60. PubMed ID: 7734354
[TBL] [Abstract][Full Text] [Related]
12. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity.
Bläse M; Zaruba MM; Santo-Hoeltje L; Bamberg M; Hoffmann W; Rodemann HP
Strahlenther Onkol; 1999 Nov; 175(11):563-8. PubMed ID: 10584127
[TBL] [Abstract][Full Text] [Related]
13. Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.
Zhang X; Chen ZG; Khuri FR; Shin DM
Head Neck; 2007 Apr; 29(4):351-61. PubMed ID: 17163463
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anti-tumor effect of 13-cRA and IFN-alpha/beta in mouse renal cell carcinoma.
Taguchi I; Hara I; Gohji K; Arakawa S; Kamidono S
Int J Oncol; 1998 Jul; 13(1):145-9. PubMed ID: 9625816
[TBL] [Abstract][Full Text] [Related]
15. The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors.
Wahlberg P; Einarsdottir M; Fex G; Rydell R
Anticancer Drugs; 1997 Jun; 8(5):522-8. PubMed ID: 9215617
[TBL] [Abstract][Full Text] [Related]
16. Estramustine: a novel radiation enhancer in human carcinoma cells.
Ryu S; Gabel M; Khil MS; Lee YJ; Kim SH; Kim JH
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):99-104. PubMed ID: 7916009
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines.
Majewski S; Szmurlo A; Marczak M; Jablonska S; Bollag W
Int J Cancer; 1994 Apr; 57(1):81-5. PubMed ID: 7512078
[TBL] [Abstract][Full Text] [Related]
18. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
[TBL] [Abstract][Full Text] [Related]
19. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines.
Angioli R; Sevin BU; Perras JP; Untch M; Koechli OR; Nguyen HN; Steren A; Schwade JG; Villani C; Averette HE
Cancer; 1993 Jun; 71(11):3717-25. PubMed ID: 8490922
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers.
Massad LS; Turyk ME; Bitterman P; Wilbanks GD
Gynecol Oncol; 1996 Mar; 60(3):428-34. PubMed ID: 8774652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
